29 related articles for article (PubMed ID: 28970182)
1. Characterization of diabetic neuropathy in the Zucker diabetic Sprague-Dawley rat: a new animal model for type 2 diabetes.
Davidson EP; Coppey LJ; Holmes A; Lupachyk S; Dake BL; Oltman CL; Peterson RG; Yorek MA
J Diabetes Res; 2014; 2014():714273. PubMed ID: 25371906
[TBL] [Abstract][Full Text] [Related]
2. Protective Effect of Pemafibrate Treatment against Diabetic Retinopathy in Spontaneously Diabetic Torii Fatty Rats.
Tanaka Y; Takagi R; Mitou S; Shimmura M; Hasegawa T; Amarume J; Shinohara M; Kageyama Y; Sasase T; Ohta T; Muramatsu SI; Kakehashi A; Kaburaki T
Biol Pharm Bull; 2024 Mar; 47(3):713-722. PubMed ID: 38432946
[TBL] [Abstract][Full Text] [Related]
3. Bone morphological analyses in Spontaneously Diabetic Torii (SDT) fatty rats.
Ohta T; Kimura S; Hirata M; Yamada T; Sugiyama T
J Vet Med Sci; 2015 Oct; 77(10):1327-30. PubMed ID: 26004433
[TBL] [Abstract][Full Text] [Related]
4. Contribution of animal models to diabetes research: Its history, significance, and translation to humans.
Yagihashi S
J Diabetes Investig; 2023 Sep; 14(9):1015-1037. PubMed ID: 37401013
[TBL] [Abstract][Full Text] [Related]
5. Dapagliflozin protects neural and vascular dysfunction of the retina in diabetes.
Luo Q; Leley SP; Bello E; Dhami H; Mathew D; Bhatwadekar AD
BMJ Open Diabetes Res Care; 2022 May; 10(3):. PubMed ID: 35577387
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiological features in the brains of female Spontaneously Diabetic Torii (SDT) fatty rats.
Maekawa T; Sugimoto M; Kume S; Ohta T
J Vet Med Sci; 2022 Mar; 84(3):330-337. PubMed ID: 35082197
[TBL] [Abstract][Full Text] [Related]
7. Sodium-glucose co-transporter 2 inhibitors and diabetic retinopathy: insights into preservation of sight and looking beyond.
Lahoti S; Nashawi M; Sheikh O; Massop D; Mir M; Chilton R
Cardiovasc Endocrinol Metab; 2021 Mar; 10(1):3-13. PubMed ID: 33634250
[TBL] [Abstract][Full Text] [Related]
8. Glomerular hyperfiltration with hyperglycemia in the spontaneously diabetic Torii (SDT) fatty rat, an obese type 2 diabetic model.
Sano R; Ishii Y; Yamanaka M; Yasui Y; Kemmochi Y; Kuroki F; Sugimoto M; Fukuda S; Sasase T; Miyajima K; Nakae D; Ohta T
Physiol Res; 2021 Mar; 70(1):45-54. PubMed ID: 33453716
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiological abnormalities in the brains of Spontaneously Diabetic Torii-Lepr
Maekawa T; Ohta T; Kume S
J Vet Med Sci; 2018 Sep; 80(9):1385-1391. PubMed ID: 30012919
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiological analyses of skeletal muscle in obese type 2 diabetes SDT fatty rats.
Kemmochi Y; Ohta T; Motohashi Y; Kaneshige A; Katsumi S; Kakimoto K; Yasui Y; Anagawa-Nakamura A; Toyoda K; Taniai-Riya E; Takahashi A; Shoda T; Yamada T
J Toxicol Pathol; 2018 Apr; 31(2):113-123. PubMed ID: 29750000
[TBL] [Abstract][Full Text] [Related]
11. Diabetic peripheral neuropathy in Spontaneously Diabetic Torii-Lepr(fa) (SDT fatty) rats.
Yamaguchi T; Sasase T; Mera Y; Tomimoto D; Tadaki H; Kemmochi Y; Ohta T; Sato E; Matsushita M
J Vet Med Sci; 2012 Dec; 74(12):1669-73. PubMed ID: 22850562
[TBL] [Abstract][Full Text] [Related]
12. Female spontaneously diabetic Torii fatty rats develop nonalcoholic steatohepatitis-like hepatic lesions.
Ishii Y; Motohashi Y; Muramatsu M; Katsuda Y; Miyajima K; Sasase T; Yamada T; Matsui T; Kume S; Ohta T
World J Gastroenterol; 2015 Aug; 21(30):9067-78. PubMed ID: 26290633
[TBL] [Abstract][Full Text] [Related]
13. [Genetic rat models of type 2 diabetes for evaluation the effectiveness of minor biologically active food substances].
Mazo VK; Murashev AN; Sidorova YS; Zorin SN; Kochetkova AA
Vopr Pitan; 2014; 83(6):25-31. PubMed ID: 25929019
[TBL] [Abstract][Full Text] [Related]
14. Animal models of diabetic neuropathy: progress since 1960s.
Islam MS
J Diabetes Res; 2013; 2013():149452. PubMed ID: 23984428
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiological profiles of SDT fatty rats, a potential new diabetic peripheral neuropathy model.
Maekawa T; Tadaki H; Sasase T; Motohashi Y; Miyajima K; Ohta T; Kume S
J Pharmacol Toxicol Methods; 2017; 88(Pt 2):160-166. PubMed ID: 28970182
[TBL] [Abstract][Full Text] [Related]
16. Contribution of hyperglycemia on diabetic complications in obese type 2 diabetic SDT fatty rats: effects of SGLT inhibitor phlorizin.
Katsuda Y; Sasase T; Tadaki H; Mera Y; Motohashi Y; Kemmochi Y; Toyoda K; Kakimoto K; Kume S; Ohta T
Exp Anim; 2015; 64(2):161-9. PubMed ID: 25736710
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
